期刊文献+

美常安联合乳果糖治疗成人功能性便秘的疗效评价 被引量:7

The effect of Medilac-s combined with lactulose in the treatment of adult functional constipation
下载PDF
导出
摘要 目的评价美常安联合乳果糖在治疗成人功能性便秘中的疗效。方法选取成人功能性便秘患者81例,随机分为三组,A组28例、B组26例、C组27例。A组应用美常安联合乳果糖治疗,B组应用美常安治疗,C组应用乳果糖治疗,疗程均为4周。观察治疗后48 h首次排便率、治疗后2周、4周排便次数、患者粪便性状改善、便秘伴随症状改善、不良反应发生率等,比较三组间的差异。结果总有效率A组(92.9%)高于B组(61.5%)及C组(70.4%),差异有统计学意义;48 h内首次排便率A组(85.7%)高于B组(53.8%)及C组(59.3%),差异有统计学意义(χ2=6.567、4.450,P<0.05);治疗4周后的排便次数A组高于B组及C组,差异有统计学意义(P<0.05);治疗4周后粪便性状正常率,A组(82.1%)高于B组(57.7%)及C组(55.6%),差异有统计学意义(χ2=4.450、4.550,P<0.05)。在对腹胀、排便困难、腹痛等伴随症状改善方面,A组高于B、C两组,差异有统计学意义(P<0.05)。不良反应发生率,三组比较差异无统计学意义(P>0.05)。结论联合应用美常安及乳果糖治疗功能性便秘效果优于单用美常安或乳果糖,安全性相似。 Objective To evaluate the effect of Medilac-s combined with lactulose in treatment of adult functional constipation. Methods A total of 81 adult functional constipation patients were randomly divided into three groups. Group A(n = 28) received Medilac-s and lactulose; group B received Medilac-s only (n = 26); group C received lactulose only(n = 27). The treatment lasted for 4 weeks in each group. The difference of defecation rate within 48 hours after first dose, defecation frequency in 2 and 4 weeks, the change of feces, the clinical symptoms improvement, and the incidence of side effects were observed and compared among 3 groups. Results The total effective rates in group A, B, C were 92.9%(26/28), 61.5%(16/26), 70.4%(19/28), respectively. For the defecation rate within 48 hours after treatment,group A was significantly greater than group B and group C(χ^2 = 6.567, 4.450, P 〈 0.05). For the defecation frequency after 4 weeks treatment, group A was significantly greater than group B and group C (P 〈 0.05). For the normal rate of feces, group A was significantly greater than group B and group C (P 〈 0.05). Comparing the improvement of accompanying symptoms such as abdominal distension, defecation difficulty, abdominal pain, group A was significantly greater than group B and C (P 〈 0.05). There was no significant differences(all P 〉 0.05) in the incidence of adverse reaction among three groups. Conclusions Medilac-s and lactulose combination was better than those with Medilac-s or lactulose alone in the treatment of adult functional constipation.
作者 孔祥建 周超
出处 《现代消化及介入诊疗》 2015年第2期92-95,共4页 Modern Interventional Diagnosis and Treatment in Gastroenterology
关键词 美常安 乳果糖 成人功能性便秘 临床研究 Medilac-s Lactulose Adult functional constipation Clinical study
  • 相关文献

参考文献6

  • 1无.中国慢性便秘诊治指南(2013,武汉)[J].胃肠病学,2013,18(10):605-612. 被引量:599
  • 2Martinez AP, de Azevedo GR. The BristolStool Form Scale: its translation to Portuguese,cultural adaptation and validation. Rev Lat Am Enfermagem. 2012,20(3):583-589.
  • 3李延青,于岩波.功能性便秘的诊断与治疗[J].中国实用内科杂志,2011,31(2):158-160. 被引量:137
  • 4吕宾.肠黏膜屏障与肠功能障碍[J].现代消化及介入诊疗,2013,18(4):232-234. 被引量:43
  • 5Vieira AT, Teixeira MM, Martins FS. The role of probiotics and pre- biotics in inducing gut immunity. Front Immunol, 2013,4:445.
  • 6Ruston T, Hunter K, Cummings G, et al. Efficacy and side-effect profiles of lactulose, docusate sodium, and sennosides compared to PEG in opioid-induced constipation: a systematic review. Can On- col Nuts J, 2013,23(4):236-246.

二级参考文献35

共引文献759

同被引文献38

引证文献7

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部